430 related articles for article (PubMed ID: 27650425)
1. Female gender as independent risk factor of torsades de pointes during acquired atrioventricular block.
Chorin E; Hochstadt A; Viskin S; Rozovski U; Havakuk O; Baranchuk A; Enriquez A; Strasberg B; Guevara-Valdivia ME; Márquez MF; González-Pacheco H; Hasdemir C; Rosso R
Heart Rhythm; 2017 Jan; 14(1):90-95. PubMed ID: 27650425
[TBL] [Abstract][Full Text] [Related]
2. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.
Topilski I; Rogowski O; Rosso R; Justo D; Copperman Y; Glikson M; Belhassen B; Hochenberg M; Viskin S
J Am Coll Cardiol; 2007 Jan; 49(3):320-8. PubMed ID: 17239713
[TBL] [Abstract][Full Text] [Related]
3. Electrocardiographic predictors of bradycardia-induced torsades de pointes in patients with acquired atrioventricular block.
Cho MS; Nam GB; Kim YG; Hwang KW; Kim YR; Choi H; Kim SH; Rhee KS; Kim NJ; Kim JS; Kim J; Choi KJ; Kim YH
Heart Rhythm; 2015 Mar; 12(3):498-505. PubMed ID: 25460857
[TBL] [Abstract][Full Text] [Related]
4. Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes?
Samuelov-Kinori L; Kinori M; Kogan Y; Swartzon M; Shalev H; Guy D; Ferenidou F; Mashav N; Sadeh B; Atzmony L; Kliuk-Ben-Basat O; Steinvil A; Justo D
J Electrocardiol; 2009; 42(4):353-357.e1. PubMed ID: 19261294
[TBL] [Abstract][Full Text] [Related]
5. Fragmented QRS is associated with torsades de pointes in patients with acquired long QT syndrome.
Haraoka K; Morita H; Saito Y; Toh N; Miyoshi T; Nishii N; Nagase S; Nakamura K; Kohno K; Kusano KF; Kawaguchi K; Ohe T; Ito H
Heart Rhythm; 2010 Dec; 7(12):1808-14. PubMed ID: 20837161
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced torsades de pointes in an underserved urban population. Methadone: is there therapeutic equipoise?
Romero J; Baldinger SH; Goodman-Meza D; Engstrom K; Valencia CR; Golive A; Medrano F; Rangasamy S; Makkiya M; Fisher JD; Gross J; Krumerman A; Kim S; Garcia MJ; Di Biase L; Ferrick KJ
J Interv Card Electrophysiol; 2016 Jan; 45(1):37-45. PubMed ID: 26589717
[TBL] [Abstract][Full Text] [Related]
7. Repolarization characteristics and incidence of Torsades de Pointes in patients with acquired complete atrioventricular block.
Bozkaya YT; Eroğlu Z; Kayikçioğlu M; Payzin S; Can LH; Kültürsay H; Hasdemir C
Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():98-100. PubMed ID: 17584695
[TBL] [Abstract][Full Text] [Related]
8. Acquired long QT syndrome from stress cardiomyopathy is associated with ventricular arrhythmias and torsades de pointes.
Madias C; Fitzgibbons TP; Alsheikh-Ali AA; Bouchard JL; Kalsmith B; Garlitski AC; Tighe DA; Estes NA; Aurigemma GP; Link MS
Heart Rhythm; 2011 Apr; 8(4):555-61. PubMed ID: 21146632
[TBL] [Abstract][Full Text] [Related]
9. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.
Trinkley KE; Page RL; Lien H; Yamanouye K; Tisdale JE
Curr Med Res Opin; 2013 Dec; 29(12):1719-26. PubMed ID: 24020938
[TBL] [Abstract][Full Text] [Related]
10. Persistent atrial fibrillation is associated with reduced risk of torsades de pointes in patients with drug-induced long QT syndrome.
Darbar D; Kimbrough J; Jawaid A; McCray R; Ritchie MD; Roden DM
J Am Coll Cardiol; 2008 Feb; 51(8):836-42. PubMed ID: 18294569
[TBL] [Abstract][Full Text] [Related]
11. Torsades de pointes during complete atrioventricular block: Genetic factors and electrocardiogram correlates.
Subbiah RN; Gollob MH; Gula LJ; Davies RW; Leong-Sit P; Skanes AC; Yee R; Klein GJ; Krahn AD
Can J Cardiol; 2010 Apr; 26(4):208-12. PubMed ID: 20386770
[TBL] [Abstract][Full Text] [Related]
12. The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of Torsades de Pointes.
Tisdale JE; Rasty S; Padhi ID; Sharma ND; Rosman H
J Clin Pharmacol; 2001 Dec; 41(12):1310-8. PubMed ID: 11762558
[TBL] [Abstract][Full Text] [Related]
13. Predicting torsade de pointes in acquired long QT syndrome: optimal identification of critical QT interval prolongation.
Chiladakis J; Kalogeropoulos A; Zagkli F; Koutsogiannis N; Chouchoulis K; Alexopoulos D
Cardiology; 2012; 122(1):3-11. PubMed ID: 22626988
[TBL] [Abstract][Full Text] [Related]
14. Bradycardia-induced abnormal QT prolongation in patients with complete atrioventricular block with torsades de pointes.
Kurita T; Ohe T; Marui N; Aihara N; Takaki H; Kamakura S; Matsuhisa M; Shimomura K
Am J Cardiol; 1992 Mar; 69(6):628-33. PubMed ID: 1536113
[TBL] [Abstract][Full Text] [Related]
15. Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study.
Salem JE; Bretagne M; Lebrun-Vignes B; Waintraub X; Gandjbakhch E; Hidden-Lucet F; Gougis P; Bachelot A; Funck-Brentano C;
Arch Cardiovasc Dis; 2019 Nov; 112(11):699-712. PubMed ID: 31477476
[TBL] [Abstract][Full Text] [Related]
16. Increased propensity of women to develop torsades de pointes during complete heart block.
Kawasaki R; Machado C; Reinoehl J; Fromm B; Baga JJ; Steinman RT; Lehmann MH
J Cardiovasc Electrophysiol; 1995 Nov; 6(11):1032-8. PubMed ID: 8589872
[TBL] [Abstract][Full Text] [Related]
17. Determinants of torsades de pointes in older patients with drug-associated long QT syndrome: a case-control study.
Goutelle S; Sidolle E; Ducher M; Caron J; Timour Q; Nony P; Gouraud A
Drugs Aging; 2014 Aug; 31(8):601-9. PubMed ID: 24923384
[TBL] [Abstract][Full Text] [Related]
18. Electrocardiographic Parameters Indicating Worse Evolution in Patients with Acquired Long QT Syndrome and Torsades de Pointes.
Kukla P; Jastrzębski M; Fijorek K; Stec S; Bryniarski L; Czarnecka D; Baranchuk A
Ann Noninvasive Electrocardiol; 2016 Nov; 21(6):572-579. PubMed ID: 27018992
[TBL] [Abstract][Full Text] [Related]
19. [Torsade de pointes--a cause of Morgagni-Adam-Stokes attacks in patients with complete atrioventricular block].
Antonelli D; Rozner E; Freedberg NA; Turgeman Y
Harefuah; 2008 Mar; 147(3):204-6, 279. PubMed ID: 18488859
[TBL] [Abstract][Full Text] [Related]
20. Combined pharmacological block of I(Kr) and I(Ks) increases short-term QT interval variability and provokes torsades de pointes.
Lengyel C; Varró A; Tábori K; Papp JG; Baczkó I
Br J Pharmacol; 2007 Aug; 151(7):941-51. PubMed ID: 17533421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
